Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
22 results
D1.74 - Molecular IgE sensitization profiling in a patient with Asteraceae weed pollen allergy and anaphylaxis to honey
D1.75 - Anaphylaxis during Picc Line replacement
D1.76 - The Hot Chocolate Drink Dilemma
D1.77 - Perioperative Hypersensitivity Outcomes: A retrospective review of 112 patients seen between 2019 and 2024 at two allergy centres
D1.78 - Analytical Verification of Omega-5 gliadin (Tri a 19) Allergen Assay on the IMMULITE 2000 XPi System*
D1.79 - Cardiovascular symptoms during anaphylaxis: An analysis from the European Anaphylaxis Registry
D1.82 - Diagnostic challenges in amoxicillin-clavulanate anaphylaxis: an inconclusive in vitro study – Case Report
D1.83 - Asthma and multi-food allergy were risk factors for Oral Food Challenge failure
D1.84 - IgE-mediated allergy to chlorhexidine: case report
D1.85 - Basophil activation test in β-Lactam Anaphylaxis: A Case Series from a Tertiary Hospital
D1.86 - Hypersensitivity Reaction to Lugol’s Solution: A Case Report
D3.290 - Manifestations of allergic skin lesions in the early childhood and adult population: Epidemiological manifestations of diseases
D3.291 - Hereditary angioedema with normal C1Inh and PLG mutation treated with tranexamic acid : Beware of the risk of thrombosis
D3.292 - "Evaluating Inflammatory Markers in Chronic Spontaneous Urticaria: Impact of Omalizumab Treatment"
D3.293 - Acrodermatitis chronica atrophicans in the field of scleroderma
D3.295 - Mental health support for atopic dermatitis patients in the Republic of Kazakhstan
D3.296 - Urticaria activity, quality of life and disease control in chronic spontaneous urticaria patients in Kazakhstan
D3.298 - Monomorphic maculo-papular late age onset cutaneous mastocytosis
D3.299 - Cholinergic urticaria treated with dupilumab
D3.302 - Elevated Kocuria rhizophila contributing to repair of skin barrier function in patients with atopic dermatitis
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download